Intracranial stenting as a rescue therapy in patients with stroke-in-evolution

Woo Keun Seo, Kyungmi Oh, Sang-Il Suh, Hae Young Seol

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background The feasibility and efficacy of intracranial stenting were evaluated for patients with a stroke-in-evolution after the time window for thrombolysis. Methods Patients with symptomatic intracranial steno-occlusive disease with progressive or fluctuating symptoms were treated using intracranial stenting after the time window for hyperacute thrombolysis. Results Within the study period, we identified 10 patients (7 men, 62.5 ± 11.3 years old) who were eligible for inclusion. The median onset-to-arrival time was 5.8 hours (range:.6-144 hours), and the median onset-to-procedure time was 33 hours (range: 8-346 hours). Only 1 patient previously received intravenous thrombolysis using alteplase. The symptomatic occlusive artery was the right middle cerebral artery, left middle cerebral artery, and basilar artery in 3, 1, and 6 patients, respectively. The median initial National Institutes of Health Stroke Scale (NIHSS) score was 4 (range: 0-6), and the median NIHSS score measured immediately before the procedure was 8 (range: 4-26). All but 1 patient underwent successful angioplasty and stenting using a Wingspan stent. Reocclusion of the stented artery occurred in 1 patient, and his neurological status deteriorated to coma. A favorable outcome (modified Rankin Scale ≤2) at 3 months was noted in 7 patients (70%). Conclusion Intracranial stenting could be considered an alternative strategy for treating patients with medically intractable stroke-in-evolution.

Original languageEnglish
Pages (from-to)1411-1416
Number of pages6
JournalJournal of Stroke and Cerebrovascular Diseases
Volume25
Issue number6
DOIs
Publication statusPublished - 2016 Jun 1

Fingerprint

Stroke
Therapeutics
Middle Cerebral Artery
National Institutes of Health (U.S.)
Arteries
Basilar Artery
Tissue Plasminogen Activator
Coma
Angioplasty
Stents

Keywords

  • Brain infarct
  • neurological deterioration
  • outcome
  • stents

ASJC Scopus subject areas

  • Surgery
  • Rehabilitation
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Intracranial stenting as a rescue therapy in patients with stroke-in-evolution. / Seo, Woo Keun; Oh, Kyungmi; Suh, Sang-Il; Seol, Hae Young.

In: Journal of Stroke and Cerebrovascular Diseases, Vol. 25, No. 6, 01.06.2016, p. 1411-1416.

Research output: Contribution to journalArticle

@article{be31468f11ad40a5887bf2526fd2b44f,
title = "Intracranial stenting as a rescue therapy in patients with stroke-in-evolution",
abstract = "Background The feasibility and efficacy of intracranial stenting were evaluated for patients with a stroke-in-evolution after the time window for thrombolysis. Methods Patients with symptomatic intracranial steno-occlusive disease with progressive or fluctuating symptoms were treated using intracranial stenting after the time window for hyperacute thrombolysis. Results Within the study period, we identified 10 patients (7 men, 62.5 ± 11.3 years old) who were eligible for inclusion. The median onset-to-arrival time was 5.8 hours (range:.6-144 hours), and the median onset-to-procedure time was 33 hours (range: 8-346 hours). Only 1 patient previously received intravenous thrombolysis using alteplase. The symptomatic occlusive artery was the right middle cerebral artery, left middle cerebral artery, and basilar artery in 3, 1, and 6 patients, respectively. The median initial National Institutes of Health Stroke Scale (NIHSS) score was 4 (range: 0-6), and the median NIHSS score measured immediately before the procedure was 8 (range: 4-26). All but 1 patient underwent successful angioplasty and stenting using a Wingspan stent. Reocclusion of the stented artery occurred in 1 patient, and his neurological status deteriorated to coma. A favorable outcome (modified Rankin Scale ≤2) at 3 months was noted in 7 patients (70{\%}). Conclusion Intracranial stenting could be considered an alternative strategy for treating patients with medically intractable stroke-in-evolution.",
keywords = "Brain infarct, neurological deterioration, outcome, stents",
author = "Seo, {Woo Keun} and Kyungmi Oh and Sang-Il Suh and Seol, {Hae Young}",
year = "2016",
month = "6",
day = "1",
doi = "10.1016/j.jstrokecerebrovasdis.2016.01.054",
language = "English",
volume = "25",
pages = "1411--1416",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Intracranial stenting as a rescue therapy in patients with stroke-in-evolution

AU - Seo, Woo Keun

AU - Oh, Kyungmi

AU - Suh, Sang-Il

AU - Seol, Hae Young

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Background The feasibility and efficacy of intracranial stenting were evaluated for patients with a stroke-in-evolution after the time window for thrombolysis. Methods Patients with symptomatic intracranial steno-occlusive disease with progressive or fluctuating symptoms were treated using intracranial stenting after the time window for hyperacute thrombolysis. Results Within the study period, we identified 10 patients (7 men, 62.5 ± 11.3 years old) who were eligible for inclusion. The median onset-to-arrival time was 5.8 hours (range:.6-144 hours), and the median onset-to-procedure time was 33 hours (range: 8-346 hours). Only 1 patient previously received intravenous thrombolysis using alteplase. The symptomatic occlusive artery was the right middle cerebral artery, left middle cerebral artery, and basilar artery in 3, 1, and 6 patients, respectively. The median initial National Institutes of Health Stroke Scale (NIHSS) score was 4 (range: 0-6), and the median NIHSS score measured immediately before the procedure was 8 (range: 4-26). All but 1 patient underwent successful angioplasty and stenting using a Wingspan stent. Reocclusion of the stented artery occurred in 1 patient, and his neurological status deteriorated to coma. A favorable outcome (modified Rankin Scale ≤2) at 3 months was noted in 7 patients (70%). Conclusion Intracranial stenting could be considered an alternative strategy for treating patients with medically intractable stroke-in-evolution.

AB - Background The feasibility and efficacy of intracranial stenting were evaluated for patients with a stroke-in-evolution after the time window for thrombolysis. Methods Patients with symptomatic intracranial steno-occlusive disease with progressive or fluctuating symptoms were treated using intracranial stenting after the time window for hyperacute thrombolysis. Results Within the study period, we identified 10 patients (7 men, 62.5 ± 11.3 years old) who were eligible for inclusion. The median onset-to-arrival time was 5.8 hours (range:.6-144 hours), and the median onset-to-procedure time was 33 hours (range: 8-346 hours). Only 1 patient previously received intravenous thrombolysis using alteplase. The symptomatic occlusive artery was the right middle cerebral artery, left middle cerebral artery, and basilar artery in 3, 1, and 6 patients, respectively. The median initial National Institutes of Health Stroke Scale (NIHSS) score was 4 (range: 0-6), and the median NIHSS score measured immediately before the procedure was 8 (range: 4-26). All but 1 patient underwent successful angioplasty and stenting using a Wingspan stent. Reocclusion of the stented artery occurred in 1 patient, and his neurological status deteriorated to coma. A favorable outcome (modified Rankin Scale ≤2) at 3 months was noted in 7 patients (70%). Conclusion Intracranial stenting could be considered an alternative strategy for treating patients with medically intractable stroke-in-evolution.

KW - Brain infarct

KW - neurological deterioration

KW - outcome

KW - stents

UR - http://www.scopus.com/inward/record.url?scp=84962195754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962195754&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2016.01.054

DO - 10.1016/j.jstrokecerebrovasdis.2016.01.054

M3 - Article

VL - 25

SP - 1411

EP - 1416

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

IS - 6

ER -